5th Gene Therapy for Ophthalmic Disorders

5th Gene Therapy for Ophthalmic Disorders is a conference dedicated to delivery and drug development in gene therapies for ophthalmic diseases.

5th Gene Therapy for Ophthalmic Disorders covers topics such as:

• Validating Clinical Endpoints that Satisfy the Regulators
• Delivering Gene Therapies Effectively to the Retina
• Discovering the Latest Advances in Preclinical Models
• Pioneering Novel Vectors with Enhanced Efficacy and Safety
• Designing Effective Clinical Trials from Phase I to Phase III

5th Gene Therapy for Ophthalmic Disorders brings together professionals from the ophthalmology field.

5th Gene Therapy for Ophthalmic Disorders might be held in Massachusetts, United States in Oct 2024.